In Vitro Evaluation of N-Formimidoyl Thienamycin (MK0787) Combined with Amikacin Against Gram-Negative Bacilli and Staphylococcus aureus
AUTOR(ES)
Enciso, M. Díez
RESUMO
The in vitro synergistic activity of N-formimidoyl thienamycin and amikacin was determined against gentamicin-resistant enterobacteriaceae, Pseudomonas aeruginosa, and Staphylococcus aureus. N-Formimidoyl thienamycin showed synergism with amikacin against 19 of the gentamicin-resistant strains, 14 of the 49 strains of S. aureus, and only 1 strain of the 46 P. aeruginosa isolates.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=185722Documentos Relacionados
- Pharmacokinetics and tolerance of N-formimidoyl thienamycin (MK0787) in humans.
- Urinary Recovery of N-Formimidoyl Thienamycin (MK0787) as Affected by Coadministration of N-Formimidoyl Thienamycin Dehydropeptidase Inhibitors
- N-formimidoyl thienamycin (MK0787): in vitro study.
- In vitro activity of N-formimidoyl thienamycin (MK0787).
- N-formimidoyl thienamycin (MK0787): in vitro activity against anaerobic bacteria.